GDUFA Research Outcomes
PBPK Models
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to physiologically-based pharmacokinetics (PBPK) computational modeling to support generic product development and assessment.
-
Advancing the Use of Model-Integrated Evidence in Generic Drug Development and Assessment
Zhao, Liang
-
The Development and Framework of MMF as a Regulatory Initiative
Zhao, Liang
-
Regulatory Perspective: What Can Be a Model Master File and How to Share It?
Zhao, Liang
-
Symposium 18: Partial Area Under the Curve Analysis in Generic & New Drug Development
Gallicano, Keith
-
Quantitative Methods and Modeling to Support GDUFA Regulatory Science Research Program
Zhao, Liang
-
Regulatory Challenges and Opportunities for Model-based Approaches for Patient Pharmacokinetic (PK) Studies with Sparse Sampling Design
Zhao, Liang
-
Challenges in Using PBPK Models for Locally Acting Drug Products to Inform Regulatory Decision Making
Zhao, Liang
-
IVRT Studies During Topical Product Development: Lifecycle Management for SUPAC-SS and Generics
Yen, Cristina
-
IVPT Studies with Sunscreen Products: Experimental Parameters
Yang, Yang
-
Using PBPK Model to Support Risk Assessment for Oral Products, from a Regulatory Perspective
Wu, Fang